Arylalkene derivatives and use thereof as selective estrogen receptor modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9309211
APP PUB NO 20150018341A1
SERIAL NO

14369936

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in the prophylaxis and/or treatment of estrogen-dependent conditions or conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTAURUS BIOPHARMA CO LTDBUILDING #16 TSINGHUA SCIENCE PARK YUQUAN WISDOM VALE MINZHUANG ROAD #3 HAIDIAN DISTRICT BEIJING

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Han, Yongxin Beijing, CN 117 658
Hu, Wei Beijing, CN 354 5894
Hu, Yuandong Beijing, CN 16 65
Luo, Hong Beijing, CN 71 630
Peng, Yong Beijing, CN 54 350
Xiao, Dengming Beijing, CN 62 625
Yu, Rong Beijing, CN 71 455
Zhao, Na Beijing, CN 57 129
Zhu, Li Beijing, CN 164 1000

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00